CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, January 29, 2024
1. Approval the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2023 along with the Limited Review Report thereon. 2. Approved the Appointment of M/s Kavita Khatri & Associates Company Secretary as the Secretarial Auditor of the Company for the Financial Year 2023-24. CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for Board Meeting To Be Held On Monday, January 29, 2024
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 ,inter alia, to consider and approve 1. the Un-Audited Financial Statement for the quarter and nine months ended December 31, 2023 along with the Limited Review Report. 2.Re-Appointment of M/s Kavita Khatri & Associates Company Secretaries as a Secretarial Auditor of the Company for the Financial Year 2023-24. CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulation, 2015 CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg.74(5) of SEBI (DP) Regulations, 2018 for the Quarter Ended December 31, 2023. CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window
Intimation of Trading Window Closure CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulation, 2015 CHEMO PHARMA LABORATORIES LTD. - 506365 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper Advertisement of Unaudited Financial Services for the Quarter and Half Year Ended September 30 2023 CHEMO PHARMA LABORATORIES LTD. - 506365 - Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2023
Approval of Un-Audited Financial Results for the Quarter and Half Year Ended September 30, 2023 along with the Limited Review Report thereon. CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Outcome for Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2023
Approval of Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2023 along with the Limited Review Report thereon. CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for Board Meeting To Be Held On Friday, October 27, 2023
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 ,inter alia, to consider and approve the Un-Audited Financial Statements for the quarter and half year ended September 30, 2023 along with the Limited Review Report thereon.